Clinical Trials Directory

Trials / Completed

CompletedNCT04129242

taVNS for Upper Limb Rehabilitation

Optimization of Closed-loop Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) as a Neurorehabilitation Tool

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study explores the use of a new form of neuromodulation known as transcutaneous auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4 weeks) in chronic stroke patients. Patients will undergo a series of baseline assessments (including a brain scan), a 4-week course of motor rehabilitation, and post-assessments (including a second brain scan)

Detailed description

This study aims to refine and develop closed loop taVNS, establish activity with key biomarkers, and show initial feasibility in a small clinical trial. For paired taVNS to succeed as a clinical treatment, it is critical to develop and refine a closed-loop taVNS platform that delivers stimulation concurrently during specific movements of the motor rehabilitation training. Aim 1 develops this novel motion-gated closed-loop system that delivers taVNS in synchrony with specific upper limb motor activation (n=5) Aim 2 will combine the development of the closed-loop system with the investigator's mechanistic understanding to explore an open-label pilot trial (n=20) using closed-loop taVNS paired with task-specific training to determine the feasibility, safety, and potential effect size of this novel combination therapy.

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc TrainingA closed-loop taVNS system that delivers taVNS with upper-limb rehabilitation training in a chronic stroke population.

Timeline

Start date
2020-02-19
Primary completion
2022-10-05
Completion
2022-10-05
First posted
2019-10-16
Last updated
2024-02-28
Results posted
2024-02-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04129242. Inclusion in this directory is not an endorsement.